Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.357
+0.004 (1.05%)
At close: Apr 28, 2026, 4:00 PM EDT
0.350
-0.007 (-2.01%)
Pre-market: Apr 29, 2026, 8:19 AM EDT
Theriva Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -23.74 | -25.65 | -18.35 | -19.69 | -14.27 | |
| Depreciation & Amortization | 0.11 | 0.14 | 0.14 | 0.09 | 0.09 | |
| Loss (Gain) From Sale of Assets | 0 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | 6.92 | - | - | - | |
| Stock-Based Compensation | 0.65 | 0.67 | 0.55 | 0.48 | 0.42 | |
| Other Operating Activities | 9.37 | 0.26 | -3.64 | 0.85 | 0.17 | |
| Change in Accounts Payable | 0.07 | 0.12 | -0.16 | -0.39 | -0.36 | |
| Change in Other Net Operating Assets | -3.13 | 0.6 | 2.47 | -0.42 | 1.07 | |
| Operating Cash Flow | -16.67 | -16.94 | -19 | -19.08 | -12.89 | |
| Capital Expenditures | -0.04 | -0 | -0.2 | -0.12 | -0.01 | |
| Cash Acquisitions | - | - | - | -3.86 | - | |
| Investing Cash Flow | -0.04 | -0 | -0.2 | -4.4 | -0.01 | |
| Long-Term Debt Issued | 1.51 | - | - | - | - | |
| Long-Term Debt Repaid | -0.07 | -0.07 | -0.08 | -1.38 | - | |
| Net Debt Issued (Repaid) | 1.44 | -0.07 | -0.08 | -1.38 | - | |
| Issuance of Common Stock | 17.47 | 5.56 | 2.22 | - | 74 | |
| Repurchase of Common Stock | - | - | - | -0.29 | - | |
| Other Financing Activities | -0.71 | - | -1.52 | -3 | - | |
| Financing Cash Flow | 18.19 | 5.5 | 0.63 | -1.93 | 74 | |
| Foreign Exchange Rate Adjustments | -0.09 | -0.13 | -0.03 | -0.03 | - | |
| Net Cash Flow | 1.4 | -11.57 | -18.61 | -25.44 | 61.1 | |
| Free Cash Flow | -16.7 | -16.94 | -19.2 | -19.2 | -12.9 | |
| Free Cash Flow Per Share | -1.38 | -12.56 | -29.80 | -31.31 | -26.47 | |
| Levered Free Cash Flow | -5.98 | -10.55 | -14.41 | -10.42 | -7.51 | |
| Unlevered Free Cash Flow | -5.98 | -10.55 | -14.41 | -10.42 | -7.51 | |
| Change in Working Capital | -3.06 | 0.73 | 2.31 | -0.81 | 0.71 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.